A collaboration between McGovern Medical School at The University of Texas Health Science Center at Houston (UTHealth) and MD Anderson Cancer Center
Nivedita Thakur, MD; John M. Slopis, MD; Mary Kay Koenig, M.D.
- Provide cutting edge medical care to individuals affected by AT
- Perform state-of-the art research addressing the most critical and pertinent questions regarding the mechanisms of neurological dysfunction in Ataxia-Telangiectasia (AT)
- Translate basic science research findings into clinical therapies
- Educate medical professionals and the community about AT
- Primary and sub-specialty physicians working collaboratively to provide complete medical care for AT patients thus improving overall health and quality of life for AT patients
- The AT research center will spearhead a focused effort in performing basic and translational research aimed at treating the neurological outcomes of AT, which currently remain untreatable
- Enhance the already excellent reputation of both the medical school and the hospital by attracting patients from both a local and national patient pool
- Obtain basic science and clinical research funding. Research grants will enhance the research reputation of both institutions and also provide overhead.
- Provide outstanding and unique opportunities for teaching graduate students, medical students, residents, and fellows.
- Clinical Outpatient Service
- University of Texas Professional Building
- MD Anderson Outpatient Clinic
- Clinical Inpatient Service
- Memorial Hermann Health Care System
- MD Anderson Cancer Center
Dedicated UT Ataxia-Telangiectasia Center Staff
Nivedita Thakur, MD, Clinical Co-Director
John Slopis, MD, Clinical Co-Director
Mary Kay Koenig, MD, Clinical Co-Director
Rahmat Adejumo, MBBS, MPH, Research Director